TCG
JNJ icon

Transcendent Capital Group’s Johnson & Johnson JNJ Stock Holding History

Transcendent Capital Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,438
Closed -$352K – 133
2026
Q1 		$352K Sell
1,438
-29
-2% -$6.75K 0.16% 88
2025
Q4 		$304K Buy
1,467
+156
+12% +$30.8K 0.14% 95
2025
Q3 		$243K Buy
+1,311
New +$225K 0.11% 112
2025
Q2 		– Sell
-1,288
Closed -$214K – 106
2025
Q1 		$214K Buy
1,288
+105
+9% +$16.4K 0.12% 84
2024
Q4 		$171K Hold
1,183
– – 0.09% 109
2024
Q3 		$192K Sell
1,183
-7
-0.6% -$1.11K 0.1% 105
2024
Q2 		$174K Buy
1,190
+7
+0.6% +$1.04K 0.1% 95
2024
Q1 		$187K Hold
1,183
– – 0.11% 97
2023
Q4 		$185K Buy
+1,183
New +$181K 0.12% 77

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Transcendent Capital Group's JNJ Position: Q2 2026 in Review

Transcendent Capital Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,438 shares — an estimated $352K sold.

Transcendent Capital Group first reported a position in JNJ in Q4 2023 and held it in 9 quarters. The position peaked at $352K in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Transcendent Capital Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Transcendent Capital Group sold 1,438 Johnson & Johnson shares in Q2 2026, an estimated $352K.
  • Transcendent Capital Group first reported a position in Johnson & Johnson in Q4 2023 and held it in 9 quarters.
  • Transcendent Capital Group's Johnson & Johnson position peaked at $352K in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Transcendent Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.